Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific lite...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lin, Liu, Yajuan, Wang, Wenjing, Merritt, J. L., Yeh, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791257/
https://www.ncbi.nlm.nih.gov/pubmed/31662921
http://dx.doi.org/10.1155/2019/2313791
_version_ 1783458953196208128
author Cheng, Lin
Liu, Yajuan
Wang, Wenjing
Merritt, J. L.
Yeh, Matthew
author_facet Cheng, Lin
Liu, Yajuan
Wang, Wenjing
Merritt, J. L.
Yeh, Matthew
author_sort Cheng, Lin
collection PubMed
description Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific literature.
format Online
Article
Text
id pubmed-6791257
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67912572019-10-29 Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency Cheng, Lin Liu, Yajuan Wang, Wenjing Merritt, J. L. Yeh, Matthew Case Reports Hepatol Case Report Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific literature. Hindawi 2019-10-02 /pmc/articles/PMC6791257/ /pubmed/31662921 http://dx.doi.org/10.1155/2019/2313791 Text en Copyright © 2019 Lin Cheng et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Cheng, Lin
Liu, Yajuan
Wang, Wenjing
Merritt, J. L.
Yeh, Matthew
Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title_full Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title_fullStr Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title_full_unstemmed Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title_short Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
title_sort hepatocellular adenoma in a patient with ornithine transcarbamylase deficiency
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791257/
https://www.ncbi.nlm.nih.gov/pubmed/31662921
http://dx.doi.org/10.1155/2019/2313791
work_keys_str_mv AT chenglin hepatocellularadenomainapatientwithornithinetranscarbamylasedeficiency
AT liuyajuan hepatocellularadenomainapatientwithornithinetranscarbamylasedeficiency
AT wangwenjing hepatocellularadenomainapatientwithornithinetranscarbamylasedeficiency
AT merrittjl hepatocellularadenomainapatientwithornithinetranscarbamylasedeficiency
AT yehmatthew hepatocellularadenomainapatientwithornithinetranscarbamylasedeficiency

Ejemplares similares